Photo of Sumithra J Mandrekar

View Scopus Profile

Sumithra J Mandrekar, PhD

  • 6439 Citations
  • 41 Scopus h-Index
20032020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sumithra J Mandrekar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Data Management Core

Mandrekar, S. J. & Mandrekar, S. J.

Project: Research project

Validation of New Tumor Measurement-based Phase II Clinical Trial Endpoints

Mandrekar, S. J.

Project: Research project

Core A: Administrative Core

Mandrekar, S. J., Torbenson, M., Gores, G. J., Alberts, S. R. & Vile, R. G.

Project: Research project

Methodology for development, validation, and use of novel endpoints in oncology

Mandrekar, S. J.

2/1/14 → 1/31/18

Project: Research project

Research Output

A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)

Parikh, K., Mandrekar, S. J., Allen-Ziegler, K., Esplin, B., Tan, A. D., Marchello, B., Adjei, A. A. & Molina, J. R., Jun 1 2020, In : Oncologist. 25, 6, p. 523-531 9 p.

Research output: Contribution to journal › Article

    • A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study

    Schenk, E. L., Mandrekar, S. J., Dy, G. K., Aubry, M. C., Tan, A. D., Dakhil, S. R., Sachs, B. A., Nieva, J. J., Bertino, E., Lee Hann, C., Schild, S. E., Wadsworth, T. W., Adjei, A. A. & Molina, J. R., Jan 2020, In : Journal of Thoracic Oncology. 15, 1, p. 110-119 10 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

    Döhner, K., Thiede, C., Jahn, N., Panina, E., Gambietz, A., Larson, R. A., Prior, T. W., Marcucci, G., Jones, D., Krauter, J., Heuser, M., Voso, M. T., Ottone, T., Nomdedeu, J. F., Mandrekar, S. J., Klisovic, R. B., Wei, A. H., Sierra, J., Sanz, M. A., Brandwein, J. M. & 17 others, De Witte, T., Jansen, J. H., Niederwieser, D., Appelbaum, F. R., Medeiros, B. C., Tallman, M. S., Schlenk, R. F., Ganser, A., Serve, H., Ehninger, G., Amadori, S., Gathmann, I., Benner, A., Pallaud, C., Stone, R. M., Döhner, H. & Bloomfield, C. D., Jan 30 2020, In : Blood. 135, 5, p. 371-380 10 p.

    Research output: Contribution to journal › Article

    Open Access
    • 3 Scopus citations

    Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials

    An, M. W., Tang, J., Grothey, A. F., Sargent, D. J., Ou, F. S. & Mandrekar, S. J., Mar 2020, In : Contemporary Clinical Trials Communications. 17, 100492.

    Research output: Contribution to journal › Article

    Open Access

    • Understanding Verbosity: Funding Source and the Length of Consent Forms for Cancer Clinical Trials

    Duong, Q., Mandrekar, S. J., Winham, S. J., Cook, K., Jatoi, A. & Le-Rademacher, J. G., Jan 1 2020, (Accepted/In press) In : Journal of Cancer Education.

    Research output: Contribution to journal › Article